Deep-pocketed investors have adopted a bullish approach towards Hims & Hers Health HIMS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HIMS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 20 extraordinary options activities for Hims & Hers Health. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 65% leaning bullish and 30% bearish. Among these notable options, 6 are puts, totaling $376,235, and 14 are calls, amounting to $1,112,973.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $14.0 to $30.0 for Hims & Hers Health over the recent three months.
Volume & Open Interest Trends
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Hims & Hers Health's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims & Hers Health's whale trades within a strike price range from $14.0 to $30.0 in the last 30 days.
Hims & Hers Health Option Activity Analysis: Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | CALL | SWEEP | BULLISH | 11/08/24 | $1.8 | $1.7 | $1.8 | $20.50 | $307.7K | 401 | 1.8K |
| HIMS | PUT | SWEEP | BULLISH | 01/17/25 | $1.35 | $1.3 | $1.3 | $17.00 | $156.1K | 3.0K | 1.3K |
| HIMS | CALL | SWEEP | BEARISH | 12/20/24 | $1.0 | $0.9 | $0.9 | $27.00 | $153.1K | 87 | 1.6K |
| HIMS | CALL | SWEEP | BULLISH | 01/17/25 | $1.4 | $1.25 | $1.36 | $28.00 | $136.0K | 835 | 1.0K |
| HIMS | CALL | SWEEP | BULLISH | 11/15/24 | $5.4 | $5.3 | $5.4 | $16.00 | $134.9K | 2.0K | 313 |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims & Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Hims & Hers Health's Current Market Status
- Currently trading with a volume of 9,976,170, the HIMS's price is up by 4.05%, now at $21.18.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 0 days.
Professional Analyst Ratings for Hims & Hers Health
Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $24.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from B of A Securities persists with their Buy rating on Hims & Hers Health, maintaining a target price of $25. * Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Hims & Hers Health with a target price of $23.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Hims & Hers Health with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
